国家: 爱尔兰
语言: 英文
来源: HPRA (Health Products Regulatory Authority)
Enrofloxacin
Dopharma Research B.V.
QJ01MA90
Enrofloxacin
100 milligram(s)/millilitre
Solution for injection
POM: Prescription Only Medicine as defined in relevant national legislation
Cattle, Pigs
enrofloxacin
Antibacterial
Authorised
2014-10-10
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT DORAFLOX 100 mg/ml solution for injection for cattle and pigs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Solution for injection. Clear slightly yellowish solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle and pigs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES CATTLE Treatment of infections of the respiratory tract caused by enrofloxacin susceptible strains of_ Pasteurella multocida_, _Mannheimia haemolytica_ and_ Mycoplasma_ spp. Treatment of acute severe mastitis caused by enrofloxacin susceptible strains of_ Escherichia coli._ Treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of_ Escherichia coli_. Treatment of septicaemia caused by enrofloxacin susceptible strains of_ Escherichia coli_. Treatment of acute mycoplasma-associated arthritis due to enrofloxacin susceptible strains of_ Mycoplasma bovis_ in cattle less than 2 years old. PIGS Treatment of infections of the respiratory tract caused by enrofloxacin susceptible strains of_ Pasteurella multocida_, _Mycoplasma_ spp. and_ Actinobacillus pleuropneumoniae_. Treatment of infections of the urinary tract caused by enrofloxacin susceptible strains of_ Escherichia coli_. Treatment of post-partum dysgalactiae syndrome, PDS (MMA syndrome) caused by enrofloxacin susceptible strains of _Escherichia coli_ and_ Klebsiella_ spp. Treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of_ Escherichia coli_. Treatment of septicaemia caused by enrofloxacin susceptible strains of_ Escherichia coli._ Each ml contains: Active substance Enrofloxacin 100 mg Excipients Benzyl alcohol 7.8 mg Disodium edetate 10 mg For the full list of excipients, see section 6.1. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _ 阅读完整的文件